Clinical trial · Observational
Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors
Pilot Study of Radiologic-Pathologic Correlation in Lung Tumors Based on Core Needle Biopsy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Due to specimen collection difficulties; this study has been terminated
Summary
Brief summary (as posted)
The purpose of this study is to compare the features that the pathologist sees, when examining a lung tumor under the microscope, to the way that the tumor appears on the computed tomography (CT) scan. Features of the tumor may include abnormal blood vessels and areas in which tumor cells are dying. The samples that are taken during the needle biopsy contain information from one small part of the tumor. The investigators believe that they can show where in the tumor the samples came from, based on the CT scans during the biopsy procedure. If the investigators can accurately determine where in the tumor their samples came from, they can compare the features of that part of the tumor, as seen on the CT images, to the features of that part of the tumor as seen under the microscope. This research study also will give the investigators an idea of how much the biopsy samples are distorted in the process of preparing them for examination under the microscope.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Neoplasm | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Determination of the accuracy of registration of contrast-enhanced CT images to the CT images that show the location of the core tissue sample
Secondary outcomes (1)
- measure
- Determination of the dimensional stability of the core tissue sample: whether, and if so, how much, the length of the core sample changes as it is processed
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects who have a lung tumor that is likely to be malignant * Subjects who have been referred for percutaneous needle biopsy * The target lesion must be at least 10 mm in short-axis dimension. * Subjects must have intravenous access. * No history of significant allergy to intravenous contrast. * Subjects must have sufficient renal function to receive intravenous contrast for enhancement of the CT images. Exclusion Criteria: * Vulnerable populations will be excluded. * Subjects who lack the capacity to provide consent * Subjects who are pregnant
References
Publications (0)
Data not yet available